Form 4 holding
10%+ Owner
Hillstream BioPharma Inc.
- Security class
- Common stock
- Shares / value
- 972,222
- Estimated value
- $489,028
- Report date
- 11 Jan 2022
- Price
- $0.5030
- Ownership
- Direct
Highpoint Pharmaceuticals LLC
Insider Reports History
- Reporting-owner location
- Lewes, DE
- Latest reporting-owner signature
-
/s/ Sireesh Appajosyula
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Highpoint Pharmaceuticals LLC
Insider Reports Filed by Highpoint Pharmaceuticals LLC
3
THAR
Hillstream BioPharma Inc.
- Report period
- 11 Jan 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 11 Jan 2022, 20:45
- Role
- 10%+ Owner
- Next action
- Open filing details